A detailed history of Gray Wealth Management Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Gray Wealth Management Inc. holds 8,267 shares of PFE stock, worth $231,889. This represents 0.1% of its overall portfolio holdings.

Number of Shares
8,267
Holding current value
$231,889
% of portfolio
0.1%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

BUY
$25.89 - $29.73 $214,032 - $245,777
8,267 New
8,267 $229,000
Q3 2023

Oct 27, 2023

SELL
$32.09 - $37.51 $9,113 - $10,652
-284 Reduced 4.21%
6,457 $214,000
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $8,379 - $9,695
232 Added 3.56%
6,741 $247,000
Q1 2023

Apr 11, 2023

SELL
$39.39 - $51.28 $38,484 - $50,100
-977 Reduced 13.05%
6,509 $265,000
Q4 2022

Feb 13, 2023

BUY
$41.75 - $54.5 $13,360 - $17,440
320 Added 4.47%
7,486 $383,000
Q3 2022

Jan 03, 2023

BUY
$43.76 - $53.42 $11,115 - $13,568
254 Added 3.67%
7,166 $314,000
Q2 2022

Jan 03, 2023

BUY
$46.53 - $55.17 $28,569 - $33,874
614 Added 9.75%
6,912 $362,000
Q1 2022

Jan 03, 2023

BUY
$45.75 - $56.69 $7,914 - $9,807
173 Added 2.82%
6,298 $326,000
Q4 2021

Jan 03, 2023

BUY
$41.32 - $61.25 $10,206 - $15,128
247 Added 4.2%
6,125 $362,000
Q3 2021

Jan 03, 2023

BUY
$39.25 - $50.42 $14,718 - $18,907
375 Added 6.81%
5,878 $253,000
Q2 2021

Jan 03, 2023

SELL
$35.91 - $40.68 $10,054 - $11,390
-280 Reduced 4.84%
5,503 $216,000
Q1 2021

Jan 03, 2023

BUY
$33.49 - $37.77 $193,672 - $218,423
5,783 New
5,783 $210,000
Q4 2020

Jan 13, 2023

SELL
$33.47 - $42.56 $52,112 - $66,265
-1,557 Reduced 21.73%
5,609 $207,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Gray Wealth Management Inc. Portfolio

Follow Gray Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gray Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gray Wealth Management Inc. with notifications on news.